UBS Group’s MEDIVATION, INC. MDVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-170,000
Closed -$10.3M 8411
2016
Q2
$10.3M Buy
+170,000
New +$9.64M 0.01% 1366
2016
Q1
Sell
-1,200
Closed -$58K 8911
2015
Q4
$58K Hold
1,200
﹤0.01% 5702
2015
Q3
$51K Sell
1,200
-70,000
-98% -$3.47M ﹤0.01% 5825
2015
Q2
$4.07M Buy
71,200
+66,800
+1,518% +$4.12M ﹤0.01% 2289
2015
Q1
$284K Sell
4,400
-600
-12% -$34.4K ﹤0.01% 4600
2014
Q4
$249K Buy
+5,000
New +$260K ﹤0.01% 4832

Other funds holding MDVN

UBS Group's MDVN Position: Q3 2016 in Review

UBS Group sold out of MEDIVATION, INC. (MDVN) in Q3 2016, closing a stake of 467,641 shares — an estimated $28.2M sold.

UBS Group first reported a position in MDVN in Q4 2014 and held it in 7 quarters. The position peaked at $41.1M in Q1 2015. 53 funds tracked by Wall St. Rank hold MDVN as of Q3 2016.

  • UBS Group reported no remaining MEDIVATION, INC. position as of Q3 2016 after selling out during the quarter.
  • UBS Group sold 467,641 MEDIVATION, INC. shares in Q3 2016, an estimated $28.2M.
  • UBS Group first reported a position in MEDIVATION, INC. in Q4 2014 and held it in 7 quarters.
  • UBS Group's MEDIVATION, INC. position peaked at $41.1M in Q1 2015.
  • 53 funds tracked by Wall St. Rank held MEDIVATION, INC. as of Q3 2016.

Based on UBS Group's 13F filing for Q3 2016, filed 14 Nov 2016.